Annual report
6942.TEDINET S100YFIK
Period2025-04-01 → 2026-03-31
Filed2026-06-26
StandardIFRS
ConsolidatedYes
Data checks18 of 23 passed
Key figures · 169
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.3bn | 2025-04-01 → 2026-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥8.4bn | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥9.0bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.4bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.8bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | −¥61m | 2025-04-01 → 2026-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥345m | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Ordinary income | −¥48m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥173m | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥399m | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥889m | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥57m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥322m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥377m | 2023-04-01 → 2024-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | −¥34m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥95m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥418m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥101m | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥230m | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥21m | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥613m | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥34m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥95m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥7.2bn | at 2026-03-31 | Cons. | Assets IFRS |
| Total assets | ¥7.5bn | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥6.5bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.8bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥8.3bn | at 2024-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥7.4bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.7bn | at 2023-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥8.6bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.2bn | at 2026-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥4.4bn | at 2025-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥3.0bn | at 2026-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.0bn | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.8bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.8bn | at 2024-03-31v | Cons. | Equity IFRS |
| Net assets / equity | ¥3.1bn | at 2024-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.0bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.0bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Equity (owners) | ¥3.0bn | at 2026-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥3.0bn | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.8bn | at 2024-03-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.4bn | at 2023-03-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥2.1bn | at 2026-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥2.7bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥3.0bn | at 2024-03-31v | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥2.0bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.3bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥129m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥261m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥117m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥634m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥775m | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥411m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥257m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥378m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥377m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥27m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥39m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥151m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥475m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥848m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥704m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥332m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥191m | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥694m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥696m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-7.36 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥20.79 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-91.21 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-33.5 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥76.4 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥7.85 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥228.11 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥20.71 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥73.68 | 2023-04-01 → 2024-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥646.91 | at 2026-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥609.76 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥654.31 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥700.95 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥633.07 | at 2024-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥753.48 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥536.2 | at 2023-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥745.63 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 41.5% | at 2026-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 43.2% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.6% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 39.6% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.7% | at 2024-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 27.4% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.7% | at 2023-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 23.3% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | -1.1% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -14.1% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.3% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -3.9% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.8% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 1.0% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 36.2% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 204 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 201 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 193 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 215 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 209 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥212m | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥523m | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥278m | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥427m | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥395m | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | −¥314m | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥57m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | −¥509m | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥534m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥124m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥106m | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥115m | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥517m | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥103m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | −¥414m | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | −¥83m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | −¥74m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥56m | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥149m | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.4bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥3.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥3.1bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.5bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.0bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥803m | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.0bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.6bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.0bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥828m | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥772m | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥764m | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.2bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-89.51 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-18.01 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-24.47 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.77 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.25 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥339.75 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥429.26 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥436.94 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥307.86 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥287.1 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 66.2% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.4% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.5% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.5% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.1% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -23.3% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -4.2% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -5.3% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.0% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.3% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 4,677,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,677,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,483,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,737,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,737,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 10 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 9 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 8 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 10 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 9 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2026-03-31 | 0 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2026-03-31 | ¥250,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2026-03-31 | ¥250,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2026-03-31 | −¥15m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥31m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥31m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥503m |
| Dispensing Pharmacy And Related Businessreportable segment | employees | at 2026-03-31 | 141 pure |
| Dispensing Pharmacy And Related Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥7.0bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥7.0bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥8m |
| Dispensing Pharmacy And Related Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥364m |
| Internet Related Businessreportable segment | employees | at 2026-03-31 | 50 pure |
| Internet Related Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥1.2bn |
| Internet Related Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥1.2bn |
| Internet Related Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥10m |
| Internet Related Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥67m |
| Telecommunications Businessreportable segment | employees | at 2026-03-31 | 3 pure |
| Telecommunications Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥228m |
| Telecommunications Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥215m |
| Telecommunications Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥13m |
| Telecommunications Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥28m |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥8.4bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥8.3bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥31m |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥458m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥8.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥31m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥442m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥10m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥10m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | −¥45m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥26m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | ¥158m |
| Dispensing Pharmacy And Related Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥6.9bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥6.9bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥9m |
| Dispensing Pharmacy And Related Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥207m |
| Internet Related Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| Internet Related Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| Internet Related Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥7m |
| Internet Related Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥50m |
| Telecommunications Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥153m |
| Telecommunications Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥143m |
| Telecommunications Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥10m |
| Telecommunications Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥25m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥8.4bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥8.4bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥26m |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥232m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥26m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥187m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,514
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人アヴァンティア | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)梶 原 大 輔 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)藤 沢 秀 比 古 | |
| Audit opinion consolidated (text) | FilingDateInstant | Text · Plus | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)インターネット関連事業並びに調剤薬局及びその周辺事業におけるのれんの評価 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)監査法人アヴァンティア | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)梶 原 大 輔 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)藤 沢 秀 比 古 | |
| Audit opinion non consolidated (text) | FilingDateInstant | Text · Plus | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Revenue IFRS (5-year summary) | Prior3YearDuration | － | JPY |
| Revenue IFRS (5-year summary) | Prior2YearDuration | 9031734000 | JPY |
| Revenue IFRS (5-year summary) | Prior1YearDuration | 8360193000 | JPY |
| Revenue IFRS (5-year summary) | CurrentYearDuration | 8329806000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior3YearDuration | － | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior2YearDuration | 377120000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1YearDuration | 321961000 | JPY |
| Profit loss before tax IFRS (5-year summary) | CurrentYearDuration | -57374000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior3YearDuration | － | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior2YearDuration | 230102000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 95334000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | CurrentYearDuration | -34062000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior3YearDuration | － | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior2YearDuration | 229930000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 95709000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | CurrentYearDuration | -34265000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior3YearInstant | 1441711000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior2YearInstant | 2807461000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior1YearInstant | 3028607000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | CurrentYearInstant | 2994329000 | JPY |
| Total assets IFRS (5-year summary) | Prior3YearInstant | 7696695000 | JPY |
| Total assets IFRS (5-year summary) | Prior2YearInstant | 8336753000 | JPY |
| Total assets IFRS (5-year summary) | Prior1YearInstant | 7457618000 | JPY |
| Total assets IFRS (5-year summary) | CurrentYearInstant | 7220596000 | JPY |
| Equity to asset ratio IFRS (5-year summary) | Prior3YearInstant | 536.20 | |
| Equity to asset ratio IFRS (5-year summary) | Prior2YearInstant | 633.07 | |
| Equity to asset ratio IFRS (5-year summary) | Prior1YearInstant | 654.31 | |
| Equity to asset ratio IFRS (5-year summary) | CurrentYearInstant | 646.91 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 18 of 23 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | mismatch |
| statement vs summary · net assets | mismatch |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | mismatch |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | mismatch |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | mismatch |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |